A unique Life Sciences Graduate Academy by Clinical Professionals designed to identify, fully fund and train the most talented Life Sciences Graduates.
Bristol Myers Squibb and Exelixis have announced that a late-stage study testing a combination of Opdivo (nivolumab) and Cabometyx (cabozantinib) has hit its primary target of extending progression-free survival in certain patients with kidney cancer. https://t.co/2yseZN9vSd
.@Novartis has reached an agreement with US regulators to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalised patients with COVID-19 disease. https://t.co/RMWriOwQ3X #ClinicalTrials
In response to the COVID-19 pandemic, a large-scale randomized #clinicaltrial is to initiate in the UK to assess some of the potential treatments for COVID-19 https://t.co/8hAM5i40IG
.@AstraZeneca has unveiled plans for a randomised, global #clinicaltrial to test whether Calquence (acalabrutinib) could be used to treat the exaggerated immune response (cytokine storm) linked with COVID-19 infection in severely ill patients. https://t.co/3XtdUNEYIF
The #UKโs four chief medical officers and @NHSEngland and Improvementโs national medical director have written a joint letter to every NHS Trust in the country to encourage efforts to enrol patients into nationally prioritised #clinicaltrials on #COVID-19 https://t.co/o7TkHysWGm